FDA Inspection 1005792 — Bergen Community Regional Blood Center
The FDA completed an inspection of Bergen Community Regional Blood Center on Mar 7, 2017 in Lincoln Park, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 7, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lincoln Park, NJ (United States)